External pacemakers market seen reaching $2.09 billion by 2030

The external pacemakers market is projected to grow from $1.6 billion in 2025 to $1.7 billion in 2026, then reach $2.09 billion by 2030, according to a new industry report. Growth is tied to rising cardiovascular disease, aging populations and broader access to emergency and critical cardiac care.

Why it matters: - External pacemakers are used to temporarily regulate heart rate and support cardiac output during emergencies and procedures. - The market’s growth points to rising demand for temporary cardiac pacing as cardiovascular disease rates climb and care settings expand. - The report frames external pacemakers as a growing part of emergency cardiac care and surgical support.

What happened: - The Business Research Company released a 2026 report on the global external pacemakers market. - The market was valued at $1.6 billion in 2025 and is expected to reach $1.7 billion in 2026. - The report forecasts the market will rise to $2.09 billion by 2030. - The report puts 2025-2026 growth at a 5.9% compound annual growth rate. - The report puts 2026-2030 growth at a 5.3% compound annual growth rate. - The company also describes the market opportunity as $2.08 billion.

The details: - External pacemakers deliver electrical impulses to the heart through electrodes attached to a chest patch. - The devices are used to stabilize patients with heart rhythm issues and to provide cardiac support during surgery. - The report cites rising bradycardia cases, more acute myocardial infarctions, more cardiac surgeries, better emergency medical services and more cardiac critical care units as key drivers of historical growth. - The report cites growing cardiovascular disease burden, an aging population, stronger demand for temporary pacing, advanced cardiac care facilities and better emergency and critical care access as drivers of future growth. - The report highlights increased use in emergency cardiac care, wider adoption during surgery, demand for portable and easy-to-use devices, preference for dual chamber external pacemakers and a focus on rapid stabilization in acute situations. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The CDC reported in October 2024 that cardiovascular disease caused 919,032 deaths in the U.S. in 2023, about one in every three deaths. - Centers for Medicare & Medicaid Services data released in December 2024 showed U.S. healthcare spending rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies, future trends and updated graphics and tables. - The report offers a free sample and full report online: Download a free sample and View the full report.

Between the lines: - The report’s growth outlook suggests external pacing demand is being pulled by both clinical need and system-level investment. - North America’s lead reflects mature healthcare infrastructure, while Asia-Pacific’s faster growth points to catch-up spending and expanding cardiac care capacity. - The emphasis on portable, dual chamber and easy-to-use devices suggests buyers are prioritizing flexibility in acute-care settings.

What's next: - The market is expected to keep expanding as cardiovascular disease, aging populations and emergency care demand rise. - Report coverage suggests device makers will compete on portability, ease of use and faster stabilization in acute care. - Healthcare investment and critical care capacity will remain key variables for regional growth.